Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar;57(3):338-342.
doi: 10.1038/s41409-021-01542-0. Epub 2022 Jan 7.

Clinical trials: design, endpoints and interpretation of outcomes

Megan Othus  1 , Mei-Jie Zhang  2 , Robert Peter Gale  3
Affiliations
Editorial

Clinical trials: design, endpoints and interpretation of outcomes

Megan Othus et al. Bone Marrow Transplant. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

MO is a consultant for Daiichi Sankyo, Biosight, and Merck and is on independent data safety monitoring boards for Celgene and Glycomimetics. RPG is a consultant to BeiGene Ltd., Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc. CStone Pharmaceuticals, NexImmune Inc. and Prolacta Bioscience; advisor to Antengene Biotech LLC, Medical Director, FFF Enterprises Inc.; partner, AZAC Inc.; Board of Directors, Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd.

References

    1. Zheng C, Dai R, Gale R, Zhang M. Causal inference in randomized clinical trials. Bone Marrow Transplantation 2019; 55(1): 4–8. - PubMed
    1. Jabbour J, Manana B, Zahreddine A, Al-Shaar L, Bazarbachi A, Blaise D et al. Vitamins and minerals intake adequacy in hematopoietic stem cell transplant: results of a randomized controlled trial. Bone Marrow Transplantation 2021; 56(5): 1106–1115. - PubMed
    1. Kantarjian HM, DeAngelo DJ, Stelljes M, Martinelli G, Liedtke M, Stock W et al. Inotuzumab ozogamicin versus standard therapy for acute lymphoblastic leukemia. New England Journal of Medicine 2016; 375(8): 740–753. - PMC - PubMed
    1. DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. New England Journal of Medicine 2020; 383(7): 617–629. - PubMed
    1. Kantarjian H, Stein A, Gökbuget N, Fielding AK, Schuh AC, Ribera J-M et al. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. New England Journal of Medicine 2017; 376(9): 836–847. - PMC - PubMed

Publication types

LinkOut - more resources